skip to main content
Language:
Refined by: collection: IngentaConnect Journals remove language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Article 		Add to e-Shelf

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

Baselga, José, Dr ; Bradbury, Ian, PhD ; Eidtmann, Holger, MD ; Di Cosimo, Serena, MD ; de Azambuja, Evandro, MD ; Aura, Claudia, MD ; Gómez, Henry, MD ; Dinh, Phuong, MD ; Fauria, Karine, PhD ; Van Dooren, Veerle, MSc ; Aktan, Gursel, MD ; Goldhirsch, Aron, MD ; Chang, Tsai-Wang, MD ; Horváth, Zsolt, MD ; Coccia-Portugal, Maria, MD ; Domont, Julien, MD ; Tseng, Ling-Min, MD ; Kunz, Georg, MD ; Sohn, Joo Hyuk, MD ; Semiglazov, Vladimir, MD ; Lerzo, Guillermo, MD ; Palacova, Marketa, MD ; Probachai, Volodymyr, MD ; Pusztai, Lajos, DPhil ; Untch, Michael, PhD ; Gelber, Richard D, PhD ; Piccart-Gebhart, Martine, PhD

The Lancet (British edition), 2012-02, Vol.379 (9816), p.633-640 [Peer Reviewed Journal]

Kidlington: Elsevier Ltd

Full text available

Citations Cited by
2
AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer
AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer
Material Type:
Article 		Add to e-Shelf

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer

GIANNI, Luca ; ROMIEU, Gilles H ; CHAN, Stephen ; WARDLEY, Andrew ; GREIL, Richard ; MOORE, Nicola ; PROT, Sylvie ; PALLAUD, Celine ; SEMIGLAZOV, Vladimir ; LICHINITSER, Michail ; SERRANO, Sergio V ; MANSUTTI, Mauro ; PIVOT, Xavier ; MARIANI, Paola ; ANDRE, Fabrice ; CHAN, Arlene ; LIPATOV, Oleg

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1719-1725 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by
3
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
Material Type:
Article 		Add to e-Shelf

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Stephen Johnston ; John Pippen, Jr ; Xavier Pivot ; Mikhail Lichinitser ; Saeed Sadeghi ; Veronique Dieras ; Henry Leonidas Gomez ; Gilles Romieu ; Alexey Manikhas ; M. John Kennedy ; Michael F. Press ; Julie Maltzman ; Allison Florance ; Lisa O'Rourke ; Cristina Oliva ; Steven Stein ; Mark Pegram

Journal of clinical oncology, 2009-11, Vol.27 (33), p.5538-5546 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by
4
Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer
Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer
Material Type:
Article 		Add to e-Shelf

Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer

BRUGGER, Wolfram ; TRILLER, Nadja ; TRUNZER, Kerstin ; CAPPUZZO, Federico ; BLASINSKA-MORAWIEC, Maria ; CURESCU, Stefan ; SAKALAUSKAS, Raimundas ; MOISEEVICH MANIKHAS, Georgy ; MAZIERES, Julien ; WHITTOM, Renaud ; WARD, Carol ; MAYNE, Karen

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4113-4120 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by
5
Identification of the relationship between biomarkers of autophagy, apoptosis and inflammation in the acute period of atherothrombotic ischemic stroke
Identification of the relationship between biomarkers of autophagy, apoptosis and inflammation in the acute period of atherothrombotic ischemic stroke
Material Type:
Article 		Add to e-Shelf

Identification of the relationship between biomarkers of autophagy, apoptosis and inflammation in the acute period of atherothrombotic ischemic stroke

Lugovaya, A. V. ; Kalinina, N. M. ; Ivanov, A. M. ; Nikitin, Yu. V. ; Sukhina, I. А. ; Mitreikin, V. F. ; Semenova, E. V.

Medit͡s︡inskai͡a︡ immunologii͡a, 2023-06, Vol.25 (4), p.939-946 [Peer Reviewed Journal]

St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists

Full text available

Citations Cited by
6
Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
Material Type:
Article 		Add to e-Shelf

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation

Ionin, V. A. ; Barashkova, E. I. ; Ananev, A. M. ; Pavlova, V. A. ; Zaslavskaya, E. L. ; Baranova, E. I.

Uchenye zapiski (Sankt-Peterburgskiĭ gosudarstvennyĭ medit͡s︡inskiĭ universitet im. akad. I.P. Pavlova), 2022-11, Vol.29 (3), p.91-100 [Peer Reviewed Journal]

Academician I.P. Pavlov First St. Petersburg State Medical University

Full text available

Citations Cited by
7
DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
Material Type:
Article 		Add to e-Shelf

DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION

Ogurkova, O. N. ; Kruchinkina, E. V. ; Gusakova, A. M. ; Suslova, T. E. ; Ryabov, V. V.

Medit͡s︡inskai͡a︡ immunologii͡a, 2021-10, Vol.23 (4), p.839-844 [Peer Reviewed Journal]

St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists

Full text available

Citations Cited by
8
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Material Type:
Article 		Add to e-Shelf

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

ROBERT, Nicholas J ; DIERAS, Véronique ; PHAN, See-Chun ; O'SHAUGHNESSY, Joyce ; GLASPY, John ; BRUFSKY, Adam M ; BONDARENKO, Igor ; LIPATOV, Oleg N ; PEREZ, Edith A ; YARDLEY, Denise A ; CHAN, Stephen Y. T ; XIAN ZHOU

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1252-1260 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by
9
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Material Type:
Article 		Add to e-Shelf

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

YARDLEY, Denise A ; ISMAIL-KHAN, Roohi R ; MELICHAR, Bohuslav ; LICHINITSER, Mikhail ; MUNSTER, Pamela N ; KLEIN, Pamela M ; CRUICKSHANK, Scott ; MILLER, Kathy D ; LEE, Min J ; TREPEL, Jane B

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2128-2135 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by
10
Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
Material Type:
Article 		Add to e-Shelf

Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma

San Miguel, Jesús F ; Schlag, Rudolf ; Khuageva, Nuriet K ; Dimopoulos, Meletios A ; Shpilberg, Ofer ; Kropff, Martin ; Spicka, Ivan ; Petrucci, Maria Teresa ; Palumbo, Antonio ; Samoilova, Olga S ; Dmoszynska, Anna ; Abdulkadyrov, Kudrat M ; Delforge, Michel ; Jiang, Bin ; Mateos, Maria-Victoria ; Anderson, Kenneth C ; Esseltine, Dixie-Lee ; Liu, Kevin ; Deraedt, William ; Cakana, Andrew ; van de Velde, Helgi ; Richardson, Paul G

Journal of clinical oncology, 2013-02, Vol.31 (4), p.448-455 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Show only

  1. Full Text Online (152)
  2. Peer-reviewed Journals (155)

Creation Date 

From To
Refine
  1. Before2003  (7)
  2. 2003To2008  (10)
  3. 2009To2013  (32)
  4. 2014To2019  (77)
  5. After 2019  (35)
  6. More options open sub menu

Language 

  1. English  (149)
  2. Japanese  (11)
  3. Ukrainian  (3)
  4. French  (2)
  5. German  (2)
  6. More options open sub menu

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far